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Poster Session II 151chemotherapy. Future implications for patients with lymphoma to
collect with G-CSF and chemotherapy are under consideration as
well as the utilization of the drug, AMD-3100 (AnorMED, Inc).422
EFFICACY OF MOUTH RINSES DURING CYTARABINE INFUSION IN
PREVENTING ORAL MUCOSITIS IN THE RECIPIENTS OF ALLOGENEIC
HEMATOPOIETIC STEM CELL TRANSPLANTATION CONDITIONED BY
HIGH-DOSE CYTARABINE AND TOTAL BODY IRRRADIATION
Hasegawa, K.1, Okabe, A.1, Kawada, Y.1, Tsujimura, N.1, Yashima, T.1,
Kobayashi, N.1, Kondo, S.1, Mori, T.2, Okamoto, S.2. 1Keio University
Hospital, Tokyo, Japan; 2Keio Univeristy School of Medicine, Tokyo,
Japan.
Background: Oral mucositis is one of the serious and frequent
conditioning-associated toxicities of allogeneic hematopoietic
stem cell transplantation (HSCT).We recently reported that cytar-
abine is excreted in the saliva after its high-dose administration, and
the cytarabine exreted in the saliva could play some role in causing
oral mucositis after HSCT (Anti-Cancer Drugs 2006; 17; 597).
Based on this finding, the efficacy of mouth rinses during cytarabine
infusion in preventing oral mucositis was prospectively evaluated in
allogeneic HSCT recipients treated with high-dose cytarabine.
Patients andMethods: Fifteen patients who underwent allogeneic
HSCT at Keio University Hospital between November 2006 and
June 2007 after being conditioned with TBI and high-dose cytara-
bine as described below were evaluated. Following TBI (12 Gy), cy-
tarabine at a dose of 3 g/m2 was administered intravenously over 2
hours every 12 hours for 4 consecutive days. Stem cells were bone
marrow from related (n 5 4) or unrelated (n 5 11) donor. Patients
were instructed to rinse their mouth with cold water every 10 min-
utes for 2 hours during cytarabine infusion and for additional 1 hour
after completion of cyrabine infusion. The grades of oral mucositits
were evaluated using National Cancer Institute Common Toxicity
Criteria (NCI-CTC) every day from the day of the first dose of cy-
tarabine to day 28 after HSCT and the maximum grade of each pa-
tient was considered as his or her grade.Results:The grades of oral
mucositis in 15 patients who performedmouth rinses wereGrade 0–
1 in 9 patients, and Grade 2 in 6 patients (40%): no patients devel-
opedGrade 3 oral mucositis. The grades of oral mucositis in control
patients receiving the same conditioning without mouth rinses (n5
35) were Grade 0–1 in 7, Grade 2 in 19 patients (54.3%), and Grade
3 in 9 patients (25.7%). Incidence of Grades 2–3 and Grade 3 oral
mucositis were significantly lower in patients who performedmouth
rinses as compared with control patients (40% vs. 80%; P5 0.009,
0% vs. 25.7%; P 5 0.02, respectively). Conclusion: Our findings
suggest that mouth rinses during cytarabine infusion could reduce
the incidence of oral mucositis caused by high-dose cytarabine. Al-
though this efficacy of mouth rinses is considered primarily due to
the removal of excreted cytarabine in the saliva, synergistic or addi-
tive effect of oral cryotherapy might contribute to the efficacy since
cold water was used for mouth rinses.423
LOWER LEGMUSCLE STRENGTH AND FATIGUE IN PATIENTS RECEIVING
HEMATOPOIETIC CELL TRANSPLANTATION UP TO TWOMONTHS AFTER
HOSPITAL DISCHARGE
Tonosaki, A. St Luke’s College of Nursing, Chuo-ku, Tokyo, Japan.
Purpose: To identify the factors relating to fatigue receiving
BMT up to two months after hospital discharge in order to provid
nursing care for early recovery.Method:The study was conducted
from November 2002 to November 2006. Sixty-six participants
were recruited at ResearchHospital of The Institute ofMedical Sci-
ence at Tokyo, Japan. Eligibility criteria for participation in the
study were: (1) more than 18 years old (2) scheduled for first time
transplantation (3) no uncontrolled hypertension, uncontrolled
pain, or unstable bone lesion. Approval was obtained from the ethics
committees at the hospital and authors’ belonging institution. Par-
ticipants were measured leg muscle strength (knee extension, ankle
plantar flexion, dorsiflexion strengths, and cross-sectional area ofthe thigh), State-Trait Anxiety Inventory (STAI-S) and Cancer Fa-
tigue Scale for Japanese (CFS). The measurement was performed
for 3 times, those were before entering the laminar air flow (LAF)
room, before hospital discharge and about two months after dis-
charge. In addition, steps per day was recorded by pedometer and
food intake data was collected from medical records. Multiple re-
gression analysis using stepwise regression (SPSS ver.14.0) was con-
ducted for factors relating to fatigue score after discharge. Result:
Twenty-five subjects who completed all 3 time-measurements
were examined. Twenty-two subjects had received cord blood
transplantation and three subjects had received BMT. The average
steps per day were 3304.8 (SD 1846.10) at twomonths after hospital
discharge. Post-transplantation days required to intake at least half
of meal portions (hereafter referred to as food intake recovery) was
91.1 (SD 42.21) days, and a significant correlation was noted be-
tween STAI-S and CFS for all points. Multiple regression analysis
demonstrated positive paths from food intake recovery (b5 .359;
P 5 .049) and average steps per day after discharge (b5 .357; P 5
.056) and negative path from ankle plantar flexion strength before
discharge (b5 -.435; P5 .020) to fatigue scores at two month after
discharge. Steps per day at after discharge was significantly corre-
lated with Cognitive domain in CFS after discharge (r 5 .566,
P 5 .003, n 5 25) Discussion: Results indicated that patients
may suffer from weakness during walking due to reduced muscle
strength in the ankle joints after transplantation. So preventive resis-
tance training should be started after early stage transplantation.424
PEDIATRIC PHERESIS LEG SPLINT IMMOBILIZATION TO INCREASE EFFI-
CIENCY OF STEM CELL COLLECTION AND CONTROL FEMORAL PHERE-
SIS CATHETER MALFUNCTIONS
Yocco, M., Healy, D., Barnes, Y., Chadakhtzian, A., Heidotten, A.,
Shenoy, S., Hayashi, R. St. Louis Chidren’s Hospital, St. Louis, MO.
Problem:Femoral pheresis cathetermafunction has been a recur-
ring problem in the infant to three year old population at St. Louis
Childrens Hospital. The very young pediatric patient would en-
counter problems with pheresis due to their inability to maintain
leg alignment during the procedure, resulting in kinked and ob-
structed femoral pheresis lines. The pheresis line malfunctions of-
ten require second pheresis line placement, increase cost and
length of hospital stay, increase sedation and sometimes result in
missing peak collection dates due to the line malfunction. Plan:
Prior to pheresis the patient was measured and a soft pheresis leg
splint was designed to immobilize the patients leg in which the phe-
resis catheter would be placed. The pheresis leg splint was placed on
the patient in the recovery room and remained in place until the
pheresis process was completed. Evaluation: The evaluation of
our experience with a active infant who underwent pheresis, while
utilizing the pheresis leg splint, was very positive. The patient re-
quired three days of pheresis to meet the stem cell goal and the
splint remained intact through out the process. The pheresis leg
splint maintained the proper alignment and pheresis was performed
without any catheter malfunctions. In the past it has been our expe-
rience that three days of pheresis in this age group would involve
multiple line complications and those issues made for a frustrating
pheresis experience for patient, family and healthcare providers.
Future Plans: A research study will be conducted with patients
from infant to three years of age using the pheresis leg splint and ret-
rospectively comparing a similar population of patients and their
pheresis outcomes. The catheter malfunction rate, cost and length
of hospital stay, sedation requirements and pheresis cell count will
be analyzed to determine the relevance of the pheresis leg splint
in the very young noncompliant pediatric patient population.425
IMPLEMENTATION OF A DEVELOPMENTAL FORM TO IMPROVE COM-
MUNICATION AND FOSTER CLINICAL DEVELOPMENT FOR THE BLOOD
AND MARROW TRANSPLANT NURSE AFTER THE ORIENTATION PERIOD
ENDS
Ellison, L.M. Stanford Hosptial and Clinics, Stanford, CA.
152 Poster Session IIPurpose/Background:Blood andMarrowTransplant is a highly
specialized area of nursing that requires a unique set of clinical and
assessment skills. Due to high turn over and the influx of new grad-
uates and inexperience Blood and Marrow Transplant nurses, our
unit implemented a developmental plan and daily evaluation form
for all new hires. The purpose of this form is to foster ongoing
learning after the orientation period is completed. This form also
facilitates communication and the development of critical thinking
by coaching the new hire to work closely with either the charge
nurse or a member of the management team.
The management team also developed a critical question tool to
be used by the charge nurse. The purpose of this tool is to assist the
charge nurse in asking open questions to help the new hire increase
their knowledge and clinical assessment of the Blood and Marrow
Transplant recipient. Conclusion: Both the charge nurses and
the new hires feel the daily evaluation form has helped the new hires
to provide safer and more efficient care. They also feel it has helped
to provide ongoing education regarding the unique needs of the
BMT patients. Since the implementation, the management team
has noticed the communication between the charge nurse and the
new hire has helped to not only organize their daily tasks; but
also, to see how those tasks fit into the bigger picture.426
INFUSION CONFUSION: HOW TO TEACH THE ART OF HPC INFUSION
Kramer, C.P., Fouts, T.V., Rogers, K., Naert, S., Nista, E., Garner, K.
Medical University of South Carolina, Charleston, SC.
Blood and marrow transplant centers are facing a unique educa-
tional challenge due to staff turnover rates, increasing regulations
from accrediting bodies and a greater number of novice nurses car-
ing for complex hematopoetic progenitor cell (HPC) patients.
These issues present a safety risk to this patient population and an
educational challenge to transplant centers.
The BloodMarrowTransplant Nursing Educational Committee
(BMTNEC) at the Medical University of South Carolina identified
the need to provide pertinent information on HPC infusion in a vi-
sual format that is easily accessible and presented in a timely man-
ner. A plan was devised to develop instructional media which
parallels current standards of practice in both the adult and pediatric
HPC programs. The BMTNEC reviewed policies, collaborated
with adult and pediatric nursing staff, and re-evaluated previous
quality measures, in order to identify necessary educational topics.
The goal of the project was to provide both novice and experi-
enced nurses an easily accessible, brief instructional video of a pro-
cedure not commonly performed. This poster presentation
describes the development and utilization of a five minute, step by
step, HPC infusion instructional DVD accessible at any institu-
tional computer terminal by clicking on a desktop icon.427
SUPPORTING THE SCLERODERMA PATIENT THROUGH A COMPLEX TO-
TAL BODY IRRADIATION PREPARATIVE REGIMEN WITH AUTOLGOUS
STEM CELL SUPPORT: A MULTIDISCIPLINARY APPROACH
Russell, D., Lassiter, M., Loftis, J. Duke University Health System, Dur-
ham, NC.
Scleroderma or systemic sclerosis is an autoimmune disorder
where there is thickening of the connective tissue, which can cause
damage to internal organs, such as the heart, lungs & kidneys. The
symptoms of scleroderma can bemild to life threatening. Due to the
severity of symptoms, treatment options for scleroderma are varied.
Treatment options are often managed based upon symptoms dis-
played & organ involvement. Presently, with the treatment options
available, none prevent advancement of the disease process & rever-
sal of organ damage.
Researchers have brought forth the idea that as an autoimmune
disorder, scleroderma may be effectively treated by looking at theimmune system. This idea was conceived when it was determined
that some patients who have received stem cell transplant for other
autoimmune disorders have remained in long term remission after
transplant. With this said, this concept has led to the development
of the SCOT (Scleroderma: Cyclophosphamide or Transplant)
Study. This multicenter clinical trial compares the potential bene-
fits of stem cell transplantation versus high dose monthly cyclo-
phosphamide. As principle investigator & confirmed transplant
center, Duke University Health System focuses on the patient
that is randomized to the transplant arm.
With the emergence of this study, adult stem cell transplant is
changing as we historically know it. The scleroderma patient has
never been exposed to oncology treatments, such as chemotherapy
and radiation therapy.They are unfamiliarwith potential side effects
of this treatment regimen. As well, the total body irradiation (TBI)
treatment on this protocol is more complex than the conventional
therapy traditionally used to treat oncology patients undergoing
stem cell transplantation. As a program, there has been a collabora-
tive effort between the physician team, nursing team, stressmanage-
ment and radiation therapy to prepare the patient mentally,
physically & emotionally for the transplant process. This abstract
will present strategies implemented to prepare a patient with
a non-oncological diagnosis for an intense treatment regimen.428
METHODOLOGICAL CONSIDERATIONS IN PHYSICAL AND PSYCHO-
SOCIAL INTERVENTION STUDIES IN PATIENTS UNDERGOING HEMATO-
POIETIC STEM CELL TRANSPLANTATION (SCT)
Laursen, H.B.1, Jarden, M.1, Adamsen, L.2. 1University Hospital of Co-
penhagen and Faculty of Health Sciences, University of Copenhagen and
UCSF, Copenhagen, Denmark; 2University of Copenhagen, Copenha-
gen, Denmark.
Aim: Several studies conclude that patients undergoing SCT ex-
perience physical, psychological and social deficits during and after
SCT, recommending intervention studies as a means to minimize
these. Even though only a few intervention studies are published,
they can significantly enhance our knowledge in the improvement
of nursing care. Based on the literature and the experience from
two ongoing intervention studies, we would like to discuss some
of the limitations and challenges when carrying out intervention
studies in this patient group.Discussion of Design andMethods:
Sample size: Nursing led intervention studies are often single centre
studies with a limited number of possible eligible patients. Exclu-
sion due to study design or attrition rates due to treatment compli-
cations/death can affect the total number of patients capable of
completing the study. Measurement of the effect of the interven-
tion: Many studies use quantitative methods to measure physical
and psychosocial performance before and after intervention. Most
of these questionnaires require a considerable number of patients
to show a significant effect of the intervention. As a result, the effect
may not be evident when using quantitative methods alone, but may
benefit by adding qualitative methods like semi-structured inter-
views, diaries etc. Control group bias: The intervention study may
affect the control group as well, simply because the focus of the in-
tervention is highlighted in the control group’s perception and
thereby reflected in their actions. Reproducibility and validity: In-
tervention studies are often performed by a special research nurse
who conduct all elements of the intervention, making it difficult
to separate the effect of the program and the personality of and re-
lationship with the research nurse unless more objective measures
are used. Furthermore, not all intervention programs are theoreti-
cally based and described, making it difficult to reproduce, validate
and implement the program in other SCT settings.Conclusion: In
order to gain knowledge in improving patient care during SCT, in-
tervention studies are requested. Intervention studies often include
a limited number of patients and the effect of an intervention study
may not be shown using quantitative methods alone, but may also
include qualitative methods. Intervention studies may influence
the control groups’ behaviour. It is important to be able to repro-
duce and validate intervention studies in other SCT settings.
